HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING—
Price Investing Group
← Back to Research Watchlist
BSX
Boston Scientific Corp
Healthcare Medical Devices · Massachusetts, USA · Reports in usd
—
Market Cap: $63.02B
Market Cap
$63.02B
Enterprise Val
$75.11B
P/E Ratio
17.15
P/B Ratio
2.53
Trailing PEG (1Y)
1.16
As Of
Oct 4, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$25.17B
Gross Margin70.71%
Profit Margin70.71%
Return on Equity14.94%
Return on Assets8.35%
Current Ratio1.24
Debt/Equity0.51
LT Debt/Equity0.44
Revenue Per Share3.66

Income Statement

Jun 30, 2026
Revenue$5.44B
Cost of Revenue$1.59B
Gross Profit$3.85B
R&D$554.0M
SG&A$1.80B
Operating Expenses$2.67B
Operating Income$1.18B
Interest Expense$96.0M
Tax Expense$155.0M
Net Income$907.0M
EPS (Basic)$0.62
EPS (Diluted)$0.61
EBIT$1.16B
EBITDA$1.51B
Consolidated Income$905.0M
Non-Controlling Interests-$2.0M

Balance Sheet

Jun 30, 2026
Cash & Equivalents$539.0M
Accounts Receivable$3.05B
Inventory$3.24B
Current Assets$7.97B
LT Investments$2.25B
Property, Plant & Equipment$4.13B
Intangibles$25.56B
Non-Current Assets$37.24B
Total Assets$45.22B
Accounts Payable$1.23B
Current Debt$1.71B
Current Liabilities$6.43B
LT Debt$10.92B
Non-Current Liabilities$13.62B
Total Liabilities$20.04B
Total Debt$12.62B
Retained Earnings$7.82B
Shareholder Equity$24.93B
Shares Outstanding1,486,355,179

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow$1.47B
Investing Cash Flow-$1.96B
Financing Cash Flow-$410.0M
CapEx-$195.0M
Free Cash Flow$1.28B
Depreciation & Amort.$355.0M
Stock-Based Comp$87.0M
Acquisitions / Disposals-$256.0M
Investment Activity$0.00
Debt Issued/Repaid$1.66B
Equity Issued/Repaid-$2.00B
Dividends Paid$0.00
Net Change in Cash-$890.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h